RBC Raises Price Target on Vertex Pharmaceuticals to $600 From $576, Keeps Outperform Rating
MT newswire2026/11/03 11:52Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
07:52 AM EST, 11/03/2026 (MT Newswires) -- Vertex Pharmaceuticals (VRTX) has an average rating of overweight and mean price target of $593.30, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Solutions 30 Postpones Strategy Webinar
Bitget•2026/11/17 15:29
Correction to OFG Bancorp Rating
Dow Jones•2026/11/17 15:01
Perenti inks $670 million contract with AngloGold Ashanti at Geita gold mine
Mining.com•2026/11/17 14:55
Crypto prices
MoreBitcoin
BTC
$64,021.5
-0.57%
Ethereum
ETH
$1,781.6
-1.93%
Tether USDt
USDT
$0.9991
+0.01%
BNB
BNB
$587.71
+0.39%
USDC
USDC
$1.0000
+0.02%
XRP
XRP
$0.9648
+1.71%
Solana
SOL
$72.54
+3.02%
TRON
TRX
$0.3082
+0.97%
Hyperliquid
HYPE
$68.07
+2.59%
Zcash
ZEC
$939.05
+8.14%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now